Mechanisms of tumor cell migration and invasion in lung cancer metastasis

Lung Cancer Metastasis: Novel Biological Mechanisms and Impact on Clinical Practice

Volumn , Issue , 2009, Pages 93-109

  Thodeti, Charles Kumar ^a   Ghosh, Kaustabh ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84900574217     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4419-0772-1_5     Document Type: Chapter

References (132)

1. Friedl, P. and K. Wolf, Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer, 2003, 3(5): 362-74.
2. Hood, J.D. and D.A. Cheresh, Role of integrins in cell invasion and migration. Nat Rev Cancer, 2002, 2(2): 91-100.
3. Egeblad, M. and Z. Werb, New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer, 2002, 2(3): 161-74.
4. Monteith, G.R. et al., Calcium and cancer: targeting Ca2+ transport. Nat Rev Cancer, 2007, 7(7): 519-30.
5. Sahai, E. and C.J. Marshall, RHO-GTPases and cancer. Nat Rev Cancer, 2002, 2(2): 133-42.
6. Kalluri, R., Basement membranes: structure, assembly and role in tumour angiogenesis. Nat Rev Cancer, 2003, 3(6): 422-33.
7. Vracko, R., Basal lamina scaffold-anatomy and significance for maintenance of orderly tissue structure. Am J Pathol, 1974, 77(2): 314-46.
8. Paulsson, M., Basement membrane proteins: structure, assembly, and cellular interactions. Crit Rev Biochem Mol Biol, 1992, 27(1-2): 93-127.
9. Schittny, J.C. and P.D. Yurchenco, Basement membranes: molecular organization and function in development and disease. Curr Opin Cell Biol, 1989, 1(5): 983-8.
10. Yurchenco, P.D., S. Smirnov, and T. Mathus, Analysis of basement membrane self-assembly and cellular interactions with native and recombinant glycoproteins. Methods Cell Biol, 2002, 69: 111-44.
11. Yurchenco, P.D. et al., Models for the self-assembly of basement membrane. J Histochem Cytochem, 1986, 34(1): 93-102.
12. Kalluri, R. et al., Isoform switching of type IV collagen is developmentally arrested in X-linked Alport syndrome leading to increased susceptibility of renal basement membranes to endoproteolysis. J Clin Invest, 1997, 99(10): 2470-8.
13. Wisdom, B.J. Jr. et al., Type IV collagen of Engelbreth-Holm-Swarm tumor matrix: identification of constituent chains. Connect Tissue Res, 1992, 27(4): 225-34.
14. Giannelli, G. et al., Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science, 1997, 277(5323): 225-8.
15. Ruoslahti, E. and M.D. Pierschbacher, New perspectives in cell adhesion: RGD and integrins. Science, 1987, 238(4826): 491-7.
16. Takagi, J., Structural basis for ligand recognition by RGD (Arg-Gly-Asp)-dependent integrins. Biochem Soc Trans, 2004, 32(Pt3): 403-6.
17. Ingber, D., Extracellular matrix and cell shape: potential control points for inhibition of angiogenesis. J Cell Biochem, 1991, 47(3): 236-41.
18. Ingber, D.E., Integrins, tensegrity, and mechanotransduction. Gravit Space Biol Bull, 1997, 10(2): 49-55.
19. Ingber, D.E., Cellular mechanotransduction: putting all the pieces together again. FASEB J, 2006, 20(7): 811-27.
20. Dvorak, H.F., Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med, 1986, 315(26): 1650-9.
21. Paszek, M.J. et al., Tensional homeostasis and the malignant phenotype. Cancer Cell, 2005, 8(3): 241-54.
22. Lauffenburger, D.A. and A.F. Horwitz, Cell migration: a physically integrated molecular process. Cell, 1996, 84(3): 359-69.
23. Noel, A., M. Jost, and E. Maquoi, Matrix metalloproteinases at cancer tumor-host interface. Semin Cell Dev Biol, 2008, 19(1): 52-60.
24. Rydlova, M. et al., Biological activity and clinical implications of the matrix metallopro-teinases. Anticancer Res, 2008, 28(2B): 1389-97.
25. Sternlicht, M.D. and Z. Werb, How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol, 2001, 17: 463-516.
26. Brooks, P.C. et al., Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell, 1996, 85(5): 683-93.
27. Yu, Q. and I. Stamenkovic, Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes Dev, 1999, 13(1): 35-48.
28. Yu, Q. and I. Stamenkovic, Cell surface-localized matrix metalloproteinase-9 proteolyti-cally activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev, 2000, 14(2): 163-76.
29. Yu, W.H. et al., CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling. Genes Dev, 2002, 16(3): 307-23.
30. Kajita, M. et al., Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration. J Cell Biol, 2001, 153(5): 893-904.
31. Sternlicht, M.D. et al., The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell, 1999, 98(2): 137-46.
32. Sottrup-Jensen, L., Alpha-macroglobulins: structure, shape, and mechanism of proteinase complex formation. J Biol Chem, 1989, 264(20): 11539-42.
33. Sottrup-Jensen, L. and H. Birkedal-Hansen, Human fibroblast collagenase-alpha-macro-globulin interactions. Localization of cleavage sites in the bait regions of five mammalian alpha-macroglobulins. J Biol Chem, 1989, 264(1): 393-401.
34. Sottrup-Jensen, L. et al., The alpha-macroglobulin bait region. Sequence diversity and localization of cleavage sites for proteinases in five mammalian alpha-macroglobulins. J Biol Chem, 1989, 264(27): 15781-9.
35. Coussens, L.M. et al., MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell, 2000, 103(3): 481-90.
36. Ha, H.Y. et al., Overexpression of membrane-type matrix metalloproteinase-1 gene induces mammary gland abnormalities and adenocarcinoma in transgenic mice. Cancer Res, 2001, 61(3): 984-90.
37. Itoh, T. et al., Experimental metastasis is suppressed in MMP-9-deficient mice. Clin Exp Metastasis, 1999, 17(2): 177-81.
38. Itoh, T. et al., Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res, 1998, 58(5): 1048-51.
39. Martins, S.J. et al., Prognostic relevance of TTF-1 and MMP-9 expression in advanced lung adenocarcinoma. Lung Cancer, 2008.
40. Sauter, W. et al., Matrix metalloproteinase 1 (MMP1) is associated with early-onset lung cancer. Cancer Epidemiol Biomarkers Prev, 2008, 17(5): 1127-35.
41. Zhu, Y. et al., A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility. Cancer Res, 2001, 61(21): 7825-9.
42. Chen, J.H. et al., Gaseous nitrogen oxide promotes human lung cancer cell line A549 migration, invasion, and metastasis via iNOS-mediated MMP-2 production. Toxicol Sci, 2008, 106(2): 364-75.
43. Xu, J. et al., Proteolytic exposure of a cryptic site within collagen type IV is required for angiogenesis and tumor growth in vivo. J Cell Biol, 2001, 154(5): 1069-79.
44. Huang, S. and D.E. Ingber, Cell tension, matrix mechanics, and cancer development. Cancer Cell, 2005, 8(3): 175-6.
45. Ingber, D.E., Can cancer be reversed by engineering the tumor microenvironment? Semin Cancer Biol, 2008, 18(5): 356-64.
46. Alenghat, F.J. and D.E. Ingber, Mechanotransduction: all signals point to cytoskeleton, matrix, and integrins. Sci STKE, 2002, 2002(119): PE6.
47. Woodside, D.G., S.Liu, and M.H. Ginsberg, Integrin activation. Thromb Haemost, 2001, 86(1): 316-23.
48. Shimaoka, M., J. Takagi, and T.A. Springer, Conformational regulation of integrin structure and function. Annu Rev Biophys Biomol Struct, 2002, 31: 485-516.
49. Hynes, R.O., Integrins: a family of cell surface receptors. Cell, 1987, 48(4): 549-54.
50. Hynes, R.O., Integrins: bidirectional, allosteric signaling machines. Cell, 2002, 110(6): 673-87.
51. Schwartz, M.A., Integrin signaling revisited. Trends Cell Biol, 2001, 11(12): 466-70.
52. Ng, T. et al., PKCalpha regulates beta1 integrin-dependent cell motility through association and control of integrin traffic. EMBO J, 1999, 18(14): 3909-23.
53. Thodeti, C.K. et al., ADAM12/syndecan-4 signaling promotes beta 1 integrin-dependent cell spreading through protein kinase Calpha and RhoA. J Biol Chem, 2003, 278(11): 9576-84.
54. Bos, J.L., Linking Rap to cell adhesion. Curr Opin Cell Biol, 2005, 17(2): 123-8.
55. Bos, J.L. et al., The role of Rap1 in integrin-mediated cell adhesion. Biochem Soc Trans, 2003, 31(Pt 1): 83-6.
56. Berrier, A.L. et al., Activated R-ras, Rac1, PI 3-kinase and PKCepsilon can each restore cell spreading inhibited by isolated integrin beta1 cytoplasmic domains. J Cell Biol, 2000, 151(7): 1549-60.
57. Zhang, Z. et al., Integrin activation by R-ras. Cell, 1996, 85(1): 61-9.
58. Lele, T.P., C.K. Thodeti, and D.E. Ingber, Force meets chemistry: analysis of mechan-ochemical conversion in focal adhesions using fluorescence recovery after photobleaching. J Cell Biochem, 2006, 97(6): 1175-83.
59. Parker, K.K. and D.E. Ingber, Extracellular matrix, mechanotransduction and structural hierarchies in heart tissue engineering. Philos Trans R Soc Lond B Biol Sci, 2007, 362(1484): 1267-79.
60. Chen, C.S. et al., Geometric control of cell life and death. Science, 1997, 276(5317): 1425-8.
61. Ingber, D.E. et al., Cell shape, cytoskeletal mechanics, and cell cycle control in angiogen-esis. J Biomech, 1995, 28(12): 1471-84.
62. Chrzanowska-Wodnicka, M. and K. Burridge, Rho-stimulated contractility drives the formation of stress fibers and focal adhesions. J Cell Biol, 1996, 133(6): 1403-15.
63. Riveline, D. et al., Focal contacts as mechanosensors: externally applied local mechanical force induces growth of focal contacts by an mDia1-dependent and ROCK-independent mechanism. J Cell Biol, 2001, 153(6): 1175-86.
64. Bershadsky, A., M. Kozlov, and B. Geiger, Adhesion-mediated mechanosensitivity: a time to experiment, and a time to theorize. Curr Opin Cell Biol, 2006, 18(5): 472-81.
65. Zamir, E. and B. Geiger, Molecular complexity and dynamics of cell-matrix adhesions. J Cell Sci, 2001, 114(Pt 20): 3583-90.
66. Xia, N. et al., Directional control of cell motility through focal adhesion positioning and spatial control of Rac activation. FASEB J, 2008, 22(6): 1649-59.
67. Tzima, E. et al., A mechanosensory complex that mediates the endothelial cell response to fluid shear stress. Nature, 2005, 437(7057): 426-31.
68. Delcommenne, M. and C.H. Streuli, Control of integrin expression by extracellular matrix. J Biol Chem, 1995, 270(45): 26794-801.
69. Lo, C.M. et al., Cell movement is guided by the rigidity of the substrate. Biophys J, 2000, 79(1): 144-52.
70. Yeung, T. et al., Effects of substrate stiffness on cell morphology, cytoskeletal structure, and adhesion. Cell Motil Cytoskeleton, 2005, 60(1): 24-34.
71. Guo, W. and F.G. Giancotti, Integrin signalling during tumour progression. Nat Rev Mol Cell Biol, 2004, 5(10): 816-26.
72. Chen, F.A. et al., Clones of tumor cells derived from a single primary human lung tumor reveal different patterns of beta 1 integrin expression. Cell Adhes Commun, 1994, 2(4): 345-57.
73. Owens, L.V. et al., Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors. Cancer Res, 1995, 55(13): 2752-5.
74. Weiner, T.M. et al., Expression of focal adhesion kinase gene and invasive cancer. Lancet, 1993, 342(8878): 1024-5.
75. Keely, P.J. et al., Cdc42 and Rac1 induce integrin-mediated cell motility and invasiveness through PI(3)K. Nature, 1997, 390(6660): 632-6.
76. Deryugina, E.I. et al., Functional activation of integrin alpha V beta 3 in tumor cells expressing membrane-type 1 matrix metalloproteinase. Int J Cancer, 2000, 86(1): 15-23.
77. Yilmaz, M. and G. Christofori, EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev, 2009, 28(1-2): 15-33.
78. Noren, N.K. et al., p120 catenin regulates the actin cytoskeleton via Rho family GTPases. J Cell Biol, 2000, 150(3): 567-80.
79. Noren, N.K. et al., Cadherin engagement regulates Rho family GTPases. J Biol Chem, 2001, 276(36): 33305-8.
80. Wildenberg, G.A. et al., p120-catenin and p190RhoGAP regulate cell-cell adhesion by coordinating antagonism between Rac and Rho. Cell, 2006, 127(5): 1027-39.
81. Cavallaro, U. and G. Christofori, Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat Rev Cancer, 2004, 4(2): 118-32.
82. Czyz, J., The stage-specific function of gap junctions during tumourigenesis. Cell Mol Biol Lett, 2008, 13(1): 92-102.
83. Kamibayashi, Y. et al., Aberrant expression of gap junction proteins (connexins) is associated with tumor progression during multistage mouse skin carcinogenesis in vivo. Carcinogenesis, 1995, 16(6): 1287-97.
84. Kanczuga-Koda, L. et al., Increased expression of connexins 26 and 43 in lymph node metastases of breast cancer. J Clin Pathol, 2006, 59(4): 429-33.
85. Miekus, K. et al., Contact stimulation of prostate cancer cell migration: the role of gap junctional coupling and migration stimulated by heterotypic cell-to-cell contacts in determination of the metastatic phenotype of Dunning rat prostate cancer cells. Biol Cell, 2005, 97(12): 893-903.
86. Zhang, W. et al., Increased invasive capacity of connexin43- overexpressing malignant glioma cells. J Neurosurg, 2003, 99(6): 1039-46.
87. Shimizu, K. et al., Reduced expression of the Connexin26 gene and its aberrant DNA methylation in rat lung adenocarcinomas induced by N-nitrosobis(2-hydroxypropyl)a-mine. Mol Carcinog, 2006, 45(9): 710-4.
88. Hall, A. and C.D. Nobes, Rho GTPases: molecular switches that control the organization and dynamics of the actin cytoskeleton. Philos Trans R Soc Lond B Biol Sci, 2000, 355(1399): 965-70.
89. Burridge, K. and K. Wennerberg, Rho and Rac take center stage. Cell, 2004, 116(2): 167-79.
90. DeMali, K.A., K. Wennerberg, and K. Burridge, Integrin signaling to the actin cytoske-leton. Curr Opin Cell Biol, 2003, 15(5): 572-82.
91. Tzima, E. et al., Activation of integrins in endothelial cells by fluid shear stress mediates Rho-dependent cytoskeletal alignment. EMBO J, 2001, 20(17): 4639-47.
92. Fritz, G., I. Just, and B. Kaina, Rho GTPases are over-expressed in human tumors. Int J Cancer, 1999, 81(5): 682-7.
93. Schnelzer, A. et al., Rac1 in human breast cancer: overexpression, mutation analysis, and characterization of a new isoform, Rac1b. Oncogene, 2000, 19(26): 3013-20.
94. van Golen, K.L. et al., RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype. Cancer Res, 2000, 60(20): 5832-8.
95. Paszek, M.J. and V.M. Weaver, The tension mounts: mechanics meets morphogenesis and malignancy. J Mammary Gland Biol Neoplasia, 2004, 9(4): 325-42.
96. Clark, E.A. et al., Genomic analysis of metastasis reveals an essential role for RhoC. Nature, 2000, 406(6795): 532-5.
97. Hakuma, N. et al., E1AF/PEA3 activates the Rho/Rho-associated kinase pathway to increase the malignancy potential of non-small-cell lung cancer cells. Cancer Res, 2005, 65(23): 10776-82.
98. Jayachandran, G. et al., Fragile histidine triad-mediated tumor suppression of lung cancer by targeting multiple components of the Ras/Rho GTPase molecular switch. Cancer Res, 2007, 67(21): 10379-88.
99. Shimada, T. et al., Adenoviral transfer of rho family proteins to lung cancer cells ameliorates cell proliferation and motility and increases apoptotic change. Kobe J Med Sci, 2007, 53(3): 125-34.
100. Zhang, S. et al., The tumor suppressor LKB1 regulates lung cancer cell polarity by mediating cdc42 recruitment and activity. Cancer Res, 2008, 68(3): 740-8.
101. Bhowmick, N.A. et al., Transforming growth factor-beta1 mediates epithelial to mesench-ymal transdifferentiation through a RhoA-dependent mechanism. Mol Biol Cell, 2001, 12(1): 27-36.
102. Croft, D.R. et al., Conditional ROCK activation in vivo induces tumor cell dissemination and angiogenesis. Cancer Res, 2004, 64(24): 8994-9001.
103. Matsumoto, Y. et al., Small GTP-binding protein, Rho, both increased and decreased cellular motility, activation of matrix metalloproteinase 2 and invasion of human osteo-sarcoma cells. Jpn J Cancer Res, 2001, 92(4): 429-38.
104. Xue, F. et al., Blockade of Rho/Rho-associated coiled coil-forming kinase signaling can prevent progression of hepatocellular carcinoma in matrix metalloproteinase-dependent manner. Hepatol Res, 2008, 38(8): 810-817.
105. Frederick, L.A. et al., Matrix metalloproteinase-10 is a critical effector of protein kinase Ciota-Par6alpha-mediated lung cancer. Oncogene, 2008, 27(35): 4841-53.
106. Matsui, T. et al., Rho-kinase phosphorylates COOH-terminal threonines of ezrin/radixin/moesin (ERM) proteins and regulates their head-to-tail association. J Cell Biol, 1998, 140(3): 647-57.
107. Shaw, R.J. et al., The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling. Dev Cell, 2001, 1(1): 63-72.
108. Akisawa, N. et al., High levels of ezrin expressed by human pancreatic adenocarcinoma cell lines with high metastatic potential. Biochem Biophys Res Commun, 1999, 258(2): 395-400.
109. Khanna, C. et al., Metastasis-associated differences in gene expression in a murine model of osteosarcoma. Cancer Res, 2001, 61(9): 3750-9.
110. Olson, M.F. and E. Sahai, The actin cytoskeleton in cancer cell motility. Clin Exp Metastasis, 2009, 26(4): 273-87.
111. Wang, W., R. Eddy, and J. Condeelis, The cofilin pathway in breast cancer invasion and metastasis. Nat Rev Cancer, 2007, 7(6): 429-40.
112. Keshamouni, V.G. et al., Temporal quantitative proteomics by iTRAQ 2D-LC-MS/MS and corresponding mRNA expression analysis identify post-transcriptional modulation of actin-cytoskeleton regulators during TGF-beta-Induced epithelial-mesenchymal transition. J Proteome Res, 2009, 8(1): 35-47.
113. Keshamouni, V.G. et al., Differential protein expression profiling by iTRAQ-2DLC-MS/MS of lung cancer cells undergoing epithelial-mesenchymal transition reveals a migratory/invasive phenotype. J Proteome Res, 2006, 5(5): 1143-54.
114. Mouneimne, G. et al., Spatial and temporal control of cofilin activity is required for directional sensing during chemotaxis. Curr Biol, 2006, 16(22): 2193-205.
115. van Rheenen, J. et al., EGF-induced PIP2 hydrolysis releases and activates cofilin locally in carcinoma cells. J Cell Biol, 2007, 179(6): 1247-59.
116. Varambally, S. et al., Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression. Cancer Cell, 2005, 8(5): 393-406.
117. Feng, Y. and C.A. Walsh, The many faces of filamin: a versatile molecular scaffold for cell motility and signalling. Nat Cell Biol, 2004, 6(11): 1034-8.
118. Bedolla, R.G. et al., Nuclear versus cytoplasmic localization of filamin A in prostate cancer: immunohistochemical correlation with metastases. Clin Cancer Res, 2009, 15(3): 788-96.
119. Boyden, S., The chemotactic effect of mixtures of antibody and antigen on polymorpho-nuclear leucocytes. J Exp Med, 1962, 115: 453-66.
120. Zigmond, S.H., Ability of polymorphonuclear leukocytes to orient in gradients of chemo-tactic factors. J Cell Biol, 1977, 75(2 Pt 1): 606-16.
121. Goncharova, E.A., D.A. Goncharov, and V.P. Krymskaya, Assays for in vitro monitoring of human airway smooth muscle (ASM) and human pulmonary arterial vascular smooth muscle (VSM) cell migration. Nat Protoc, 2006, 1(6): 2933-9.
122. Von Offenberg Sweeney, N. et al., Cyclic strain-mediated regulation of vascular endothe-lial cell migration and tube formation. Biochem Biophys Res Commun, 2005, 329(2): 573-82.
123. Thodeti CK, F.C., Nielsen CK, Holck P, Sundberg C, Kveiborg M, Mahalingam Y, Albrechtsen R, Couchman JR, Wewer UM., Hierarchy of ADAM12 binding to integrins in tumor cells. Exp Cell Res, 2005, 309: 438-50.
124. Dittmar, T. et al., Induction of cancer cell migration by epidermal growth factor is initiated by specific phosphorylation of tyrosine 1248 of c-erbB-2 receptor via EGFR. FASEB J, 2002, 16(13): 1823-5.
125. Niggemann, B. et al., Tumor cell locomotion: differential dynamics of spontaneous and induced migration in a 3D collagen matrix. Exp Cell Res, 2004, 298(1): 178-87.
126. Brandt, B. et al., 3D-extravasation model-selection of highly motile and metastatic cancer cells. Semin Cancer Biol, 2005, 15(5): 387-95.
127. Sahai, E., Illuminating the metastatic process. Nat Rev Cancer, 2007, 7(10): 737-49.
128. Folkman, J., Antiangiogenesis in cancer therapy-endostatin and its mechanisms of action. Exp Cell Res, 2006, 312(5): 594-607.
129. Maeshima, Y. et al., Identification of the anti-angiogenic site within vascular basement membrane-derived tumstatin. J Biol Chem, 2001, 276(18): 15240-8.
130. Albert, J.M. et al., Integrin alpha v beta 3 antagonist Cilengitide enhances efficacy of radiotherapy in endothelial cell and non-small-cell lung cancer models. Int J Radiat Oncol Biol Phys, 2006, 65(5): 1536-43.
131. Kuwada, S.K., Drug evaluation: Volociximab, an angiogenesis-inhibiting chimeric monoclonal antibody. Curr Opin Mol Ther, 2007, 9(1): 92-8.
132. Thodeti, C.K., et al., TRPV4 channels mediate cyclic strain-induced endothelial cell reorientation through integrin-to-integrin signaling. Circ Res. 2009, 104(9): 1123-30.